Literature DB >> 15122781

High sensitivity C-reactive protein values do not reliably predict the severity of histological changes in NAFLD.

Jason M Hui, Geoffrey C Farrell, James G Kench, Jacob George.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15122781     DOI: 10.1002/hep.20223

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  19 in total

Review 1.  Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.

Authors:  Emer Fitzpatrick; Anil Dhawan
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Oral choline tolerance test as a novel noninvasive method for predicting nonalcoholic steatohepatitis.

Authors:  Kento Imajo; Masato Yoneda; Koji Fujita; Takaomi Kessoku; Wataru Tomeno; Yuji Ogawa; Yoshiyasu Shinohara; Yusuke Sekino; Hironori Mawatari; Yuichi Nozaki; Hiroyuki Kirikoshi; Masataka Taguri; Gen Toshima; Junichiro Takahashi; Satoru Saito; Koichiro Wada; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2013-03-16       Impact factor: 7.527

Review 3.  Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic.

Authors:  Kareem Hassan; Varun Bhalla; Mohammed Ezz El Regal; H Hesham A-Kader
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

4.  Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease.

Authors:  Anil Arora; Praveen Sharma
Journal:  J Clin Exp Hepatol       Date:  2012-07-21

5.  The Role of Three-Dimensional Magnetic Resonance Elastography in the Diagnosis of Nonalcoholic Steatohepatitis in Obese Patients Undergoing Bariatric Surgery.

Authors:  Alina M Allen; Vijay H Shah; Terry M Therneau; Sudhakar K Venkatesh; Taofic Mounajjed; Joseph J Larson; Kristin C Mara; Phillip J Schulte; Todd A Kellogg; Michael L Kendrick; Travis J McKenzie; Suzanne M Greiner; Jiahui Li; Kevin J Glaser; Michael L Wells; Jun Chen; Richard L Ehman; Meng Yin
Journal:  Hepatology       Date:  2019-03-15       Impact factor: 17.425

6.  Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease.

Authors:  Veeral Ajmera; Emily R Perito; Nathan M Bass; Norah A Terrault; Katherine P Yates; Ryan Gill; Rohit Loomba; Anna Mae Diehl; Bradley E Aouizerat
Journal:  Hepatology       Date:  2016-10-12       Impact factor: 17.425

Review 7.  Nonalcoholic fatty liver disease and the coronary artery disease.

Authors:  Sombat Treeprasertsuk; Francisco Lopez-Jimenez; Keith D Lindor
Journal:  Dig Dis Sci       Date:  2010-05-13       Impact factor: 3.199

8.  Biomarkers in nonalcoholic fatty liver disease: a new era in diagnosis and staging of disease in children.

Authors:  Ariel E Feldstein; Valerio Nobili
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-10       Impact factor: 2.839

Review 9.  Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease.

Authors:  Neven Baršić; Ivan Lerotić; Lea Smirčić-Duvnjak; Vedran Tomašić; Marko Duvnjak
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

Review 10.  Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.

Authors:  Quentin M Anstee; Giovanni Targher; Christopher P Day
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-19       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.